Utility of Mammography for Chronic Kidney Disease Patients Undergoing Kidney Transplant Evaluation.

CONCLUSIONS: As we found no independent differences in biopsy or malignancy between age groups, it is reasonable for transplant centers to use the same evaluation MMG screening policy for all women ≥40. However, since malignancy risk increased with higher breast density, a lower threshold for additional workup may be warranted in patients with dense breasts or an indeterminate lesion on MMG. This article is protected by copyright. All rights reserved.
PMID: 26855387 [PubMed - as supplied by publisher]

Source: Clinical Breast Cancer - February 8, 2016 Category: Cancer & Oncology Authors: Stoecker JB, Cote DR, Augustine JJ, Sarabu N, Schulak JA, Sanchez EQ, Humphreville VR, Ammori JB, Woodside KJ Tags: Clin Transplant Source Type: research